ATXAMPLIA THERAPEUTICS LIMITED
Benefit of Narmafotinib in kRas-Mutated Cancer Models
- Date and time
- Announcement type
- Company Update
Show detailsHide details
- Category
- Other
- Report codes
- 11001
- Sector
- Health Care
- Industry group
- Pharmaceuticals, Biotechnology & Life Sciences